Bendamustine Hydrochloride Injection
Product Images NDC 83831-183

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 83831-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Progression-free Survival (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 01)

This text presents data on the Survival Distribution Function related to a Study Treatment comparing Bendamustine Hydrochloride and Chlorambucil in terms of Progression-Free Survival measured in months. The information seems to be organized in a tabular format for evaluation and comparison purposes.*

FDA Label Image

Bendamustine Hydrochloride Injection 100 mg_4 mL Ct (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 02)

Each mL of this medication contains bendamustine hydrochloride, equivalent to 22.7 mg of bendamustine free base. This is a hazardous drug for intravenous use only. The recommended dosage and storage instructions are provided for the healthcare provider. It must be diluted in a specific solution before administration. The vials have specific precautions and limitations, including storage conditions. This information is essential for the proper use and handling of the medication.*

FDA Label Image

Bendamustine Hydrochloride Injection 100 mg_4 mL Vial (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 03)

This is a description of a pharmaceutical product, likely related to an injection containing bendamustine hydrochloride. The text includes details such as the size of the unvarnished area (10x20mm) and recommended dosage information. It also mentions dilution requirements for the concentrate solution. The product is labeled with caution regarding concentration and includes instructions for administration. The text may also contain mentions of unwinding direction and specific concentrations of the solution (100 mg/4 mL).*

FDA Label Image

Image (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 107 1)

FDA Label Image

Image (6c0bc00a Dd5f 4305 85d6 Bd534e947e32 82 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.